Identification of widespread, closely related Acinetobacter baumannii isolates in Portugal as a subgroup of European clone II

Clinical Microbiology and Infection

Volumn 13, Issue 2, 2007, Pages 190-195

  da Silva, G ^a   Dijkshoorn, L ^b   van der Reijden, T ^b   van Strijen, B ^b   Duarte, A ^c  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY OF LISBON   (Portugal)

Author keywords

Acinetobacter baumannii; AFL Panalysis; Epidemiology; Multidrug resistance; Nosocomial infection; Typing

Indexed keywords

AMIKACIN; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; SULTAMICILLIN; TICARCILLIN; TIMENTIN; TOBRAMYCIN;

ACINETOBACTER BAUMANNII; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; DNA FINGERPRINTING; HUMAN; MOLECULAR CLONING; MOLECULAR PHYLOGENY; MULTIDRUG RESISTANCE; NONHUMAN; PORTUGAL; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; RANDOM AMPLIFIED POLYMORPHIC DNA; STRAIN DIFFERENCE;

ACINETOBACTER BAUMANNII;

EID: 33846286139     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2006.01628.x     Document Type: Article

References (19)

1. Bergogne-Bérézin E, Towner KJ. Acinetobacter spp. as nosocomial pathogens: Microbiological, clinical and epidemiological features. Clin Microbiol Rev 1996; 9: 148-165.
2. Bou G, CerveróG, Domínguez MA et al. PCR based DNA fingerprinting (REP-PCR, AP-PCR) and pulsed field gel electrophoresis characterization of a nosocomial outbreak caused by imipenem and meropenem resistant Acinetobacter baumannii. Clin Microbiol Infect 2000; 6: 635-643.
3. Sang-Oh L, Nam JK, Sang-Ho C et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: A case-control study. Antimicrob Agents Chemother 2004; 48: 224-228.
4. Corbella X, Montero A, Pujol M et al. Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii. J Clin Microbiol 2000; 38: 4086-4095.
5. Zarrilli RM, Crispino M, Bagattini E et al. Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol 2004; 42: 946-953.
6. Manikal VM, Landman D, Saurina G et al. Endemic carbapenem resistant Acinetobacter species in Brooklyn, New York: Citywide prevalence, interinstitutional spread, and relation to antibiotic usage. Clin Infect Dis 2000; 31: 101-106.
7. Dijkshoorn L, Aucken H, Gerner-Smidt P et al. Comparison of outbreak and nonoutbreak Acinetobacter baumannii strains by genotypic and phenotypic methods. J Clin Microbiol 1996; 34: 1519-1525.
8. Nemec A, Janda L, Melter O, Dijkshoorn L. Genotypic and phenotypic similarity of multiresistant Acinetobacter baumannii isolates in the Czech Republic. J Med Microbiol 1999; 48: 287-296.
9. Nemec A, Dolzani L, Brisse S et al. Diversity of aminoglycoside-resistance genes and their association with class 1 integrons among strains of pan-European Acinetobacter baumannii clones. J Med Microbiol 2004; 53: 1233-1240.
10. van Dessel H, Dijkshoorn L, van der Reijden T et al. Identification of a new geographically widespread multiresistant Acinetobacter baumannii clone from European hospitals. Res Microbiol 2004; 155: 105-112.
11. Wroblewska MM, Dijkshoorn L, Marchel H et al. Outbreak of nosocomial meningitis caused by Acinetobacter baumannii in neurosurgical patients. J Hosp Infect 2004; 57: 300-307.
12. Da Silva GJ, Quinteira S, Bértolo E et al. Long term dissemination of an OXA-40 carbapenemase-producing Acinetobacter baumannii clone in the Iberian Peninsula. J Antimicrob Chemother 2004; 54: 255-258.
13. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk susceptibility testing, 9th informational supplement. M100-S9. Wayne, PA: NCCLS, 2000.
14. Maslow JN, Slutsky AM, Arbeit RD. Application of pulsed-field gel electrophoresis to molecular epidemiology. In: Persing DH, Smith TF, Tenover FC, White TJ, eds, Diagnostic molecular microbiology: Principles and applications. Washington, DC: American Society for Microbiology, 1993; 563-572.
15. Seifert H, Dolzani L, Bressan R et al. Standardization and interlaboratory reproducibility assessment of pulsed-field gel electrophoresis-generated fingerprints of Acinetobacter baumannii. J Clin Microbiol 2005; 43: 4328-4335.
16. Grundmann H, Towner KJ, Dijkshoorn L et al. Multicenter study using standardized protocols and reagents for evaluation of reproducibility of PCR-based fingerprinting of Acinetobacter spp. J Clin Microbiol 1997; 35: 3071-3077.
17. Nemec A, De Baere T, Tjernberg I et al. Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol 2001; 51: 1891-1899.
18. Dijkshoorn L, Van Harsselaar B, Tjernberg I et al. Evaluation of amplified ribosomal DNA restriction analysis for identification of Acinetobacter genomic species. Syst Appl Microbiol 1998; 21: 33-39.
19. Tenover FC, Arbeit RD, Goering RV et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995; 33: 2233-2239.